Application of nano-LC-based glycomics towards biomarker discovery

Bioanalysis

Volumn 3, Issue 22, 2011, Pages 2573-2585

  Hua, Serenus ^a   Lebrilla, Carlito ^a,b   An, Hyun Joo ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCAN;

CARBOHYDRATE ANALYSIS; DERIVATIZATION; FLUORESCENCE ANALYSIS; GLYCOBIOLOGY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; INTERMETHOD COMPARISON; ION MOBILITY SPECTROMETRY; LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; NANOANALYSIS; NANOBIOTECHNOLOGY; NANOCHIP; POROSITY; PROCESS DEVELOPMENT; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; GLYCOMICS; HUMANS; NANOPARTICLES; POLYSACCHARIDES;

EID: 82455188350     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.263     Document Type: Review

References (94)

1. Rapoport E, Pendu J. Glycosylation alterations of cells in late phase apoptosis from colon carcinomas. Glycobiology 9(12), 1337-1345 (1999).
2. Hauptmann P, Riel C, Kunz-Schughart LA, Fröhlich K-U, Madeo F, Lehle L. Defects in N-glycosylation induce apoptosis in yeast. Mol. Microbiol.59(3), 765-778 (2006).
3. Pili R, Chang J, Partis RA, Mueller RA, Chrest FJ, Passaniti A. The a-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis and inhibits tumor growth. Cancer Res. 55(13), 2920-2926 (1995).
4. Saito T, Miyoshi E, Sasai K et al. A secreted type of b-1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation. J. Biol. Chem. 277(19), 17002-17008 (2002).
5. Wang X-Q, Sun P, O'Gorman M, Tai T, Paller AS. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppresion of activation. Glycobiol. 11(7), 515-522 (2001).
6. Duchesne L, Tissot B, Rudd TR, Dell A, Fernig DG. N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding. J. Biol. Chem. 281(37), 27178-27189 (2006).
7. Triantis V, Saeland E, Bijl N, Oude-Elferink RP, Jansen PLM. Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1. Hepatology 52(2), 656-666 (2010).
8. Guo H-B, Lee I, Kamar M, Akiyama SK, Pierce M. Aberrant N-glycosylation of β1 integrin causes reduced α5β1 integrin clustering and stimulates cell migration. Cancer Res. 62(23), 6837-6845 (2002).
9. Nita-Lazar M, Noonan V, Rebustini I, Walker J, Menko AS, Kukuruzinska MA. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res. 69(14), 5673-5680 (2009).
10. Baum LG. Developing a taste for sweets. Immunity 16, 5-8 (2002).
11. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473(1), 67-95 (1999).
12. Dube DH, Bertozzi CR. Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4(6), 477-488 (2005).
13. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Ann. Rev. Immunol. 25(1), 21-50 (2007).
14. Ianni M, Manerba M, Di Stefano G et al. Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. Immun. Ageing 7(Suppl. 1), S6 (2010).
15. de Leoz MLA, Young LJT, An HJ et al. High-mannose glycans are elevated during breast cancer progression. Mol. Cell. Proteomics 10(1), M110.002717 (2011).
16. An HJ, Miyamoto S, Lancaster KS et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J. Proteome Res. 5(7), 1626-1635 (2006).
17. Kirmiz C, Li B, An HJ et al. A serum glycomics approach to breast cancer biomarkers. Mol. Cell. Proteomics 6(1), 43-55 (2007).
18. Leiserowitz GS, Lebrilla C, Miyamoto S et al. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int. J. Gynecol. Cancer 18(3), 470-475 (2008).
19. de Leoz MLA, An HJ, Kronewitter S et al. Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines. Disease Markers 25(4), 243-258 (2008).
20. Bereman MS, Young DD, Deiters A, Muddiman DC. Development of a robust and high-throughput method for profiling N-linked glycans derived from plasma glycoproteins by nano-LC-FTICR mass spectrometry. J. Proteome Res. 8(7), 3764-3770 (2009).
21. Tang ZQ, Varghese RS, Bekesova S et al. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J. Proteome Res. 9(1), 104-112 (2010).
22. Bereman MS, Williams TI, Muddiman DC. Development of a nano-LC LTQ w™ mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control and epithelial ovarian cancer patients. Anal. Chem. 81(3), 1130-1136 (2008).
23. Zhao J, Simeone DM, Heidt D, Lubman DM, Anderson MA. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J. Proteome Res. 5(7), 1792-1802 (2006).
24. Reggi M, Capon C, Wieruszeski J-M, Michel R, Gharib B, Fournet B. The glycan moiety of human pancreatic lithostathine. Eur. J. Biochem. 230(2), 503-510 (1995).
25. An HJ, Lebrilla CB. Suppression of sialylated by sulfated oligosaccharides in negative MALDI-FTMS. Israel J. Chem. 41(2), 117-128 (2001).
26. Chervet JP, Ursem M, Salzmann JP. Instrumental requirements for nanoscale liquid chromatography. Anal. Chem. 68(9), 1507-1512 (1996).
27. Wuhrer M, Koeleman CAM, Deelder AM, Hokke CH. Normal-phase nanoscale liquid chromatography-mass spectrometry of underivatized oligosaccharides at low-femtomole sensitivity. Anal. Chem. 76(3), 833-838 (2003).
28. Karlsson NG, Wilson NL, Wirth H-J, Dawes P, Joshi H, Packer NH. Negative ion graphitised carbon nano-liquid chromatography-mass spectrometry increases sensitivity for glycoprotein oligosaccharide analysis. Rapid Commun. Mass Spectrom. 18(19), 2282-2292 (2004).
29. Cipollo JF, Awad AM, Costello CE, Hirschberg CB. N-glycans of caenorhabditis elegans are specific to developmental stages. J. Biol. Chem. 280(28), 26063-26072 (2005).
30. Yodoshi M, Tani A, Ohta Y, Suzuki S. Optimized conditions for high-performance liquid chromatography analysis of oligosaccharides using 7-amino-4- methylcoumarin as a reductive amination reagent. J. Chromatogr. A 1203(2), 137-145 (2008).
31. Prater BD, Connelly HM, Qin Q, Cockrill SL. High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry. Anal. Biochem. 385(1), 69-79 (2009).
32. Viseux N, de Hoffmann E, Domon B. Structural analysis of permethylated oligosaccharides by electrospray tandem mass spectrometry. Anal. Chem. 69(16), 3193-3198 (1997).
33. Delaney J, Vouros P. Liquid chromatography ion trap mass spectrometric analysis of oligosaccharides using permethylated derivatives. Rapid Commun. Mass Spectrom. 15(5), 325-334 (2001).
34. Alley WR, Madera M, Mechref Y, Novotny MV. Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer biomarker discovery. Anal. Chem. 82(12), 5095-5106 (2010).
35. Mechref Y, Novotny MV. Miniaturized separation techniques in glycomic investigations. J. Chromatogr. B 841(1-2), 65-78 (2006).
36. Hemström P, Irgum K. Hydrophilic interaction chromatography. J. Separation Science 29(12), 1784-1821 (2006).
37. Wuhrer M, de Boer AR, Deelder AM. Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry. Mass Spectrometry Reviews, 28(2), 192-206 (2009).
38. Takegawa Y, Ito H, Keira T, Deguchi K, Nakagawa H, Nishimura S-I. Profiling of N- and O-glycopeptides of erythropoietin by capillary zwitterionic type of hydrophilic interaction chromatography/electrospray ionization mass spectrometry. Journal of Separation Science, 31(9), 1585-1593 (2008).
39. Ruhaak LR, Uh H-W, Beekman M et al. Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. J. Proteome Res. 10(4), 1667-1674 (2010).
40. Saldova R, Royle L, Radcliffe CM et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17(12), 1344-1356 (2007).
41. Abd Hamid UM, Royle L, Saldova R et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18(12), 1105-1118 (2008).
42. Ahn J, Bones J, Yu YQ, Rudd PM, Gilar M. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 μm sorbent. J. Chromatogr. B 878(3-4), 403-408 (2010).
43. Bones J, Mittermayr S, O'Donoghue N, Guttman AS, Rudd PM. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal. Chem. 82(24), 10208-10215 (2010).
44. Mariño K, Lane JA, Abrahams JL et al. Method for milk oligosaccharide profiling by 2-aminobenzamide labelling and hydrophilic interaction chromatography (HILIC).Glycobiology 21(10), 1317-1330 (2011).
45. Zhao J, Qiu W, Simeone DM, Lubman DM. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J. Proteome Res. 6(3), 1126-1138 (2007).
46. Staples GO, Bowman MJ, Costello CE et al. A chip-based amide-HILIC LC-MS platform for glycosaminoglycan glycomics profiling. Proteomics, 9(3), 686-695 (2009).
47. Koizumi K, Okada Y, Fukuda M. High-performance liquid chromatography of mono- and oligo-saccharides on a graphitized carbon column. Carbohydrate Res. 215(1), 67-80 (1991).
48. Davies M, Smith KD, Harbin A-M, Hounsell EF. High-performance liquid chromatography of oligosaccharide alditols and glycopeptides on a graphitized carbon column. J. Chromatogr. A 609(1-2), 125-131 (1992).
49. Packer NH, Lawson MA, Jardine DR, Redmond JW. A general approach to desalting oligosaccharides released from glycoproteins. Glycoconjugate Journal 15(8), 737-747 (1998).
50. Davies MJ, Smith KD, Carruthers RA, Chai W, Lawson AM, Hounsell EF. Use of a porous graphitised carbon column for the high-performance liquid chromatography of oligosaccharides, alditols and glycopeptides with subsequent mass spectrometry analysis. J. Chromatogr. A 646(2), 317-326 (1993).
51. Davies MJ, Hounsell EF. Comparison of separation modes of high-performance liquid chromatography for the analysis of glycoprotein- and proteoglycan-derived oligosaccharides. J. Chromatogr. A 720(1-2), 227-233 (1996).
52. Wilson NL, Schulz BL, Karlsson NG, Packer NH. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J. Proteome Res. 1(6), 521-529 (2002).
53. Karlsson NG, Packer NH. Analysis of O-linked reducing oligosaccharides released by an in-line flow system. Anal. Biochem. 305(2), 173-185 (2002).
54. Schulz BL, Packer NH, Karlsson NG. Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis. Anal. Chem. 74(23), 6088-6097 (2002).
55. Karlsson NG, Schulz BL, Packer NH. Structural determination of neutral O-linked oligosaccharide alditols by negative ion LC-electrospray-MSn. J. Am. Soc. Mass Spectrom. 15(5), 659-672 (2004).
56. Whistler RL, Durso DF. Chromatographic separation of sugars on charcoal. J. Am. Chem. Soc. 72(2), 677-679 (1950).
57. Barroso B, Dijkstra R, Geerts M, Lagerwerf F, Veelen PV, Ru AD. On-line high-performance liquid chromatography/ mass spectrometric characterization of native oligosaccharides from glycoproteins. Rapid Commun. Mass Spectrom. 16(13), 1320-1329 (2002).
58. Kurokawa T, Wuhrer M, Lochnit G, Geyer H, Markl J, Geyer R. Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal(β1-6)Man-motifs. Eur. J. Biochem. 269(22), 5459-5473 (2002).
59. Niñonuevo M, An H, Yin H et al. Nanoliquid chromatography-mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high-accuracy mass analyzer. Electrophoresis 26(19), 3641-3649 (2005).
60. Bäckström M, Thomsson KA, Karlsson H, Hansson GC. Sensitive liquid chromatography-electrospray mass spectrometry allows for the analysis of the O-glycosylation of immunoprecipitated proteins from cells or tissues: application to MUC1 glycosylation in cancer. J. Proteome Res. 8(2), 538-545 (2008).
61. Karlsson NG, Thomsson KA. Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x. Glycobiology 19(3), 288-300 (2009).
62. Hua S, An HJ, Ozcan S et al. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst 136(18), 3663-3671 (2011).
63. Pabst M, Bondili JS, Stadlmann J, Mach L, Altmann F. Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal. Chem. 79(13), 5051-5057 (2007).
64. Fan JQ, Kondo A, Kato I, Lee YC. High-performance liquid chromatography of glycopeptides and oligosaccharides on graphitized carbon columns. Anal. Biochem. 219(2), 224-229 (1994).
65. Kim Y-G, Jang K-S, Joo H-S et al. Simultaneous profiling of N-glycans and proteins from human serum using a parallel-column system directly coupled to mass spectrometry. J. Chromatogr. B 850(1-2), 109-119 (2007).
66. Kawasaki N, Ohta M, Hyuga S, Hashimoto O, Hayakawa T. Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography-mass spectrometry and liquid chromatography with tandem mass spectrometry. Anal. Biochem. 269(2), 297-303 (1999).
67. Itoh S, Kawasaki N, Ohta M et al. Simultaneous microanalysis of N-linked oligosaccharides in a glycoprotein using microbore graphitized carbon column liquid chromatography-mass spectrometry. J. Chromatogr. A 968(1-2), 89-100 (2002).
68. Robinson S, Bergström E, Seymour M, Thomas-Oates J. Screening of underivatized oligosaccharides extracted from the stems of triticum aestivum using porous graphitized carbon liquid chromatography-mass spectrometry. Anal. Chem. 79(6), 2437-2445 (2007).
69. Chu CS, Niñonuevo MR, Clowers BH et al. Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. Proteomics 9(7), 1939-1951 (2009).
70. Costello CE, Contado-Miller JM, Cipollo JF. A glycomics platform for the analysis of permethylated oligosaccharide alditols. J. Am. Soc. Mass Spectrom. 18(10), 1799-1812 (2007).
71. Bonn G. High-performance liquid chromatographic elution behaviour of oligosaccharides, monosaccharides and sugar degradation products on series-connected ion-exchange resin columns using water as the mobile phase. J. Chromatogr. A 322, 411-424 (1985).
72. Kallin E, Lönn H, Norberg T. New derivatization and separation procedures for reducing oligosaccharides. Glycoconjugate J. 3(4), 311-319 (1986).
73. Stahl B, Steup M, Karas M, Hillenkamp F. Analysis of neutral oligosaccharides by matrix-assisted laser desorption ionization mass spectrometry. Anal. Chem. 63(14), 1463-1466 (1991).
74. White DR, Hudson P, Adamson JT. Dextrin characterization by high-performance anion-exchange chromatography-pulsed amperometric detection and size-exclusion chromatography-multi-angle light scattering-refractive index detection. J. Chromatogr. A 997(1-2), 79-85 (2003).
75. Chávez-Servín JL, Castellote AI, López- Sabater MC. Analysis of mono- and di-saccharides in milk-based formulae by high-performance liquid chromatography with refractive index detection. J. Chromatogr. A 1043(2), 211-215 (2004).
76. Routier FH, Hounsell EF, Rudd PM et al. Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods. J. Immunol. Methods 213(2), 113-130 (1998).
77. Nakagawa H, Kawamura Y, Kato K et al. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal. Biochem. 226(1), 130-138 (1995).
78. Yuan J, Hashii N, Kawasaki N et al. Isotope tag method for quantitative analysis of carbohydrates by liquid chromatography-mass spectrometry. J. Chromatogr. A 1067(1-2), 145-152 (2005).
79. Nakagawa H, Hato M, Takegawa Y et al. Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients. J. Chromatogr. B 853(1-2), 133-137 (2007).
80. Mittermayr S, Bones J, Doherty M, Guttman A, Rudd PM. Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation. J. Proteome Res. 10(8), 3820-3829 (2011).
81. Royle L, Campbell MP, Radcliffe CM et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 376(1), 1-12 (2008).
82. Campbell MP, Royle L, Radcliffe CM, Dwek RA, Rudd PM. GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics 24(9), 1214-1216 (2008).
83. Ninonuevo MR, Park Y, Yin H et al. A strategy for annotating the human milk glycome. J. Agricult. Food Chem. 54(20), 7471-7480 (2006).
84. Tao N, DePeters EJ, German JB, Grimm R, Lebrilla CB. Variations in bovine milk oligosaccharides during early and middle lactation stages analyzed by high-performance liquid chromatography-chip/mass spectrometry. J. Dairy Sci. 92(7), 2991-3001 (2009).
85. Tao N, Ochonicky KL, German JB, Donovan SM, Lebrilla CB. Structural determination and daily variations of porcine milk oligosaccharides. J. Agricult. Food Chem. 58(8), 4653-4659 (2010).
86. Tao N, Wu S, Kim J et al. Evolutionary glycomics: characterization of milk oligosaccharides in primates. J. Proteome Res. 10(4), 1548-1557 (2011).
87. Bynum MA, Yin H, Felts K, Lee YM, Monell CR, Killeen K. Characterization of IgG N-glycans employing a microfluidic chip that integrates glycan cleavage, sample purification, LC separation, and MS detection. Anal. Chem. 81(21), 8818-8825 (2009).
88. Dube DH, Bertozzi CR. Glycans in cancer and inflammation -potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4(6), 477-488 (2005).
89. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5(7), 526-542 (2005).
90. Bosques CJ, Raguram S, Sasisekharan R. The sweet side of biomarker discovery. Nat. Biotech. 24(9), 1100-1101 (2006).
91. Wu S, Tao N, German JB, Grimm R, Lebrilla CB. Development of an annotated library of neutral human milk oligosaccharides. J. Proteome Res. 9(8), 4138-4151 (2010).
92. Wu S, Grimm R, German JB, Lebrilla CB. Annotation and structural analysis of sialylated human milk oligosaccharides. J. Proteome Res. 10(2), 856-868 (2010).
93. Plasencia M, Isailovic D, Merenbloom S, Mechref Y, Clemmer D. Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS. J. Am Soc. Mass Spectrom. 19(11), 1706-1715 (2008).
94. Isailovic D, Kurulugama RT, Plasencia MD et al. Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J. Proteome Res. 7(3), 1109-1117 (2008).